JOIN THE WAITLIST
Early Access to Stop Tics Without Medication
and Opportunity to Participate in Clinical Trials.
YOU ARE ON THE LIST. WELCOME TO InhibiTic™.
WE ONLY USE YOUR EMAIL FOR InhibiTic™ UPDATES. WE NEVER SHARE YOUR DATA.
EARLY ACCESS
Be first in line for engineering samples and beta testing.
CLINICAL TRIAL
Get notified when enrollment opens for our pilot study.
SHAPE THE PRODUCT
Your experience directly influences what we build.